Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. Am J Physiol Endocrinol Metab 297: E76 -E84, 2009. First published May 12, 2009 doi:10.1152/ajpendo.00014.2009The mechanism by which replacement of some dietary carbohydrates with protein during weight loss favors lipid metabolism remains obscure. In this study, we investigated the effect of an energy-restricted, high-protein/low-carbohydrate diet on lipid metabolism in obese rats. High-sucroseinduced obese rats were assigned randomly to one of two energyrestricted dietary interventions: a carbohydrate-based control diet (CD) or a high-protein diet (HPD). Lean rats of the same age were assigned as normal control. There was significantly greater improvement in fatty liver and hypertriglyceridemia with the HPD diet relative to the CD diet. Expression of genes regulated by fibroblast growth factor-21 (FGF21) and involved in liver lipolysis and lipid utilitization, such as lipase and acyl-CoA oxidase, increased in obese rats fed the HPD. Furthermore, there was an inverse correlation between levels of FGF21 gene expression (regulated by glucagon/insulin balance) and increased triglyceride concentrations in liver from obese rats. Expression of hepatic stearoyl-CoA desaturase-1 (SCD1), regulated primarily by the dietary carbohydrate, was also markedly reduced in the HPD group (similar to plasma triglyceride levels in fasting animals) relative to the CD group. In conclusion, a hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia effectively relative to a carbohydrate diet. The two cellular pathways at work behind these benefits include stimulation of hepatic lipolysis and lipid utilization mediated by FGF21 and reduction of hepatic VLDL-TG production by SCD1 regulation. calorie restriction; fibroblast growth factor-21; stearoyl-CoA desaturase-1 OBESITY IS OFTEN ASSOCIATED with insulin resistance, dyslipidemia, hypertension, and fatty liver (29, 30) . This cluster of metabolic disorders, generally accepted as a metabolic syndrome, has been shown to increase the incidence of cardiovascular disease and type 2 diabetes more than the sum of the individual components (36). Effective therapeutic strategies, both for obesity and for the full spectrum of disorders in the metabolic syndrome, are essential. Obesity results from a disruption in energy balance. Because optimal energy intake is necessary to maintain or reduce body weight, caloric restriction has proven beneficial to treating obesity (15). Composition of dietary macronutrients is also important in treating the full spectrum of obesity-related metabolic disorders (12, 21, 24, 25) . For example, substitution of some dietary carbohydrate with protein in a calorie-restricted diet has been shown to increase the ratio of fat/lean tissue loss as well as to reduce serum triglyceride (TG) levels in obese subjects (12, 21, 24, 25) . Although these studies indicate that caloric restriction, including a low ratio of dietary carbohydrate to protein (CHO:PRO), has a positive effect on lipid metabolism, the mechanism driving this benefit is not fully understood.
OBESITY IS OFTEN ASSOCIATED with insulin resistance, dyslipidemia, hypertension, and fatty liver (29, 30) . This cluster of metabolic disorders, generally accepted as a metabolic syndrome, has been shown to increase the incidence of cardiovascular disease and type 2 diabetes more than the sum of the individual components (36) . Effective therapeutic strategies, both for obesity and for the full spectrum of disorders in the metabolic syndrome, are essential. Obesity results from a disruption in energy balance. Because optimal energy intake is necessary to maintain or reduce body weight, caloric restriction has proven beneficial to treating obesity (15) . Composition of dietary macronutrients is also important in treating the full spectrum of obesity-related metabolic disorders (12, 21, 24, 25) . For example, substitution of some dietary carbohydrate with protein in a calorie-restricted diet has been shown to increase the ratio of fat/lean tissue loss as well as to reduce serum triglyceride (TG) levels in obese subjects (12, 21, 24, 25) . Although these studies indicate that caloric restriction, including a low ratio of dietary carbohydrate to protein (CHO:PRO), has a positive effect on lipid metabolism, the mechanism driving this benefit is not fully understood.
Caloric restriction represents one of the primary physiological states in which lipid utilization increases. In this state, fatty acids are supplied to the liver from the diet, from de novo lipogenesis, and from TG lipolysis in adipose and other tissues. These fatty acids are substrates for generating the ATP and ketone bodies that subsequently maintain cell survival, organ function, and whole body homeostasis. However, the free fatty acids in plasma that are generated from adipose tissue lipolysis are unable to simultaneously stimulate ␤-oxidation and generate energy substrates in the liver (5) . Because the composition of dietary macronutrients determines the balance between fatty acid supply and de novo lipogenesis, it is the central regulator of the lipid utilization/␤-oxidation ratio in conditions of caloric restriction. Although relatively low in overall mass, TG stored in the liver are metabolically important because intrahepatic TG turn over more quickly than adipose tissue TG (9) and can therefore serve as an immediate substrate for energy production. Because TG metabolism within the liver is difficult to study, relatively little is known about regulation of intracellular lipolysis and the role of intrahepatic TG lipolysis and utilization in obesity.
Recent evidence links the rising consumption of sugarsweetened soft drinks to the prevalence of obesity and to increased serum TG levels (10, 32) . High-sucrose feeding has also been shown to stimulate lipid accumulation in the liver (17) . For these reasons, we used sucrose-induced obese rats to investigate the effects of altering dietary CHO:PRO ratios on lipid metabolism under conditions of caloric restriction. Specifically, our aim was to investigate 1) the mechanism driving the favorable effect of a hypocaloric high-protein diet (HPD) on lipid metabolism and 2) the importance of intrahepatic lipolysis and lipid utilization in obese rats displaying the metabolic disorders.
MATERIALS AND METHODS
Animals. Male Sprague-Dawley (SD) rats from a local breeding colony (Japan SLC, Shizuoka, Japan) were used in all experiments. Rats were housed individually in cages and maintained at constant temperature and humidity (23 Ϯ 2°C with humidity 65-75%) with a 12:12-h light-dark (0800 -2000) cycle. Prior to the study, rats were allowed free access to tap water and chow, a standard laboratory rodent diet (MF; Oriental Yeast, Osaka, Japan) consisting of 54.4% carbohydrate, 23.6% protein, and 5.3% fat (%total energy) with an energy density of 15.0 kJ/g. The University of Tokushima Animal Use Committee approved the study, and rats were maintained according to the National Institutes of Health Guidelines for Care and Use of Laboratory Animals.
Diet and experimental design. To generate obese rats, a weight gain phase (phase 1) that involved feeding excess sucrose was conducted. Twenty male, 126-day-old SD rats (524 Ϯ 6 g) were divided into two groups. The lean group (5 rats) was fed chow and tap water ad libitum, and the obese group (15 rats) was fed chow and 30% sucrose solution ad libitum for 28 days. After 28 days, rats were weighed and forced to fast overnight (2000 -1000) for collection of blood sample. There was a significant increase in the body weight of rats in the obese group relative to those in the lean group, with the exception of two rats that were excluded from the study because they were not obese and did not demonstrate any metabolic disorders such as hypertriglyceridemia.
In the weight loss phase (phase 2), rats were switched to one of two diets, a cornstarch-based control diet (CD) or a casein-based HPD (see Table 1 for complete composition). Lean rats were fed the CD ad libitum throughout the feeding period. Obese rats were assigned randomly to two groups and fed either the CD or the HPD for 10 days under 30% caloric restrictions with reference to the mean value of energy intake by lean rats. We also conducted pair feeding by assigning obese rats into sets, each consisting of one obese CD rat and one obese HPD rat. The amount of food consumed by the obese CD rat during a 24-h period was measured, and this amount was provided to the rat in the obese HPD group in the set in one feed at 1800 on the following day. Another one of the obese HPD rats was fed the mean value that was fed to the CD group. The amount of food consumed by each rat in each group was measured every 24 h, and food was replaced daily.
Refeeding test and oral fat tolerance test. Refeeding and oral fat tolerance tests were conducted in conscious rats on days 5 and 8, respectively, of phase 2. For the refeeding test on day 5, rats that were fasted for 6 h were allowed free access to each experimental diet for 5 min. For the fat tolerance test on day 8, rats that were fasted for 6 h were administered soybean oil (2 g/kg body wt) orally. Blood samples taken from the tail vein at indicated times were used to determine the plasma parameters in each experiment.
Rat euthanization and sample collection. After 10 days of feeding during phase 2, rats forced to fast overnight (2000 -1000) were euthanized for collection of blood and tissue samples. Prior to euthanization, a blood sample from the tail vein was used to determine plasma glucose and insulin concentrations. Rats were then anesthetized with diethyl ether, and blood withdrawn from the jugular vein was used for all other measurements. After exsanguination under anesthesia, rat liver, visceral fat, pancreas, and skeletal muscle samples were harvested and weighed.
Plasma glucose, insulin, and lipid concentrations and insulin sensitivity index. Plasma glucose concentration was measured using the glucose dehydrogenase method and an Accu-Chek blood glucose meter (Roche Diagnostics, Mainz-Hechtsheim, Germany). Plasma insulin concentration was measured using an ELISA kit (Morinaga, Yokohama, Japan). Insulin sensitivity index [homeostasis model assessment of insulin resistance (HOMA-IR)] was calculated by the following equation: HOMA-IR ϭ [fasting plasma glucose (mmol/l) ϫ fasting plasma insulin (pmol/l)]/405. Plasma TG, total cholesterol, and nonesterified fatty acid (NFFA) concentrations were measured using Triglyceride E-, Cholesterol E-, and NEFA C tests (Wako Pure Chemical Industries, Osaka, Japan), respectively.
Hepatic TG concentration. Hepatic lipids were extracted using the Folch method (13) . Lipid extracts were resuspended for measurements of TG concentration using a commercial kit (Triglyceride E).
RNA preparation and quantitative RT-PCR. To assess changes in gene expression, mRNA levels of genes involved in lipid homeostasis were estimated using reverse transcription of total RNA followed by semiquantitative real-time PCR amplification. Extraction of total RNA, cDNA synthesis, and real-time PCR was performed as described previously (31) . The relative abundance of each target transcript (primer sequences in Table 2 ) was calculated by normalization to the amount of amplified product from constitutively expressed ␤-actin mRNA.
Primary liver cell cultures. Hepatocytes were isolated from normal male SD rats (180 -220 g) by use of the collagenase perfusion method (33) . Hepatocyte suspensions were plated on 35-mm plastic dishes in a final volume of 2 ml of Williams E medium (Sigma, St. Louis, MO) supplemented with 1 mol of insulin (Sigma), 1 mol of dexamethasone (Sigma), 10% (vol/vol) fetal bovine serum (Invitrogen, Grand Island, NY), and 1% (vol/ vol) penicillin-streptomycin (Sigma). After 6 h of attachment, the medium was removed and replaced with fresh supplemented E medium. Twelve hours later, the medium was removed and replaced with serum-free medium. After 8 h in culture, cells were stimulated with insulin and/or glucagon (Sigma) for 6 h, after which total RNA was extracted (n ϭ 3 in each experiment) and cDNA synthesis and real-time PCR analysis was performed.
Statistical analyses. All values are expressed as means Ϯ SE. The significance of differences was assessed between two groups using paired or unpaired two-tailed t-tests or among more than two groups using ANOVA or Kruskal-Wallis tests. The effect of dietary intervention on TG levels during oral fat tolerance tests was assessed using repeated-measures ANOVA. When a significant difference was found using ANOVA or Kruskal-Wallis tests, post hoc analyses were performed using the Student-Newman-Keuls protected least significant difference test. Spearman's rank correlation coefficient was used to calculate correlation coefficients between selected variables. Differences were considered significant at P Ͻ 0.05. Statistical analyses were performed using StatView (version 5.0-J for Windows; SAS Institute, Cary, NC).
RESULTS
Sucrose feeding induces obesity and hypertriglyceridemia. During phase 1, sucrose-fed obese rats displayed greater energy intake on average than lean rats (Fig. 1A) , and mean weight gain, body weight, and plasma TG levels in the obese group were higher than those in the lean group (Fig. 1, B and C). Since adult rats were used, weight gain involved fat deposition. Whereas plasma glucose concentration was nearly normal in the obese group, plasma insulin concentration and insulin sensitivity index were significantly higher than those of the lean group (Fig. 1, D-F) .
HPD effectively improved obesity, hypertriglyceridemia, and fatty liver. Obese rats were fed calorie-restricted diets with different compositions of macronutrients. There was no significant difference in the reduction of daily energy intake or body weight between calorie-restricted HPD and CD rats (Fig. 2, A  and B) . Caloric restriction effectively improved both obesity and hypertriglyceridemia in both obese groups (Figs. 1C and 2,  B and D) . Nonetheless, rats fed the hypocaloric HPD showed greater improvements in abdominal obesity and hypertriglyceridemia than those fed the hypocaloric CD. Whereas the weight of visceral fat and the fasting plasma TG concentration among rats in the HPD group were reduced to nearly normal levels, those measurements in the CD group remained significantly higher than in the lean group (Fig. 2, C and D) . Relative weights of other organs, including liver, pancreas, and skeletal muscle, as well as other plasma parameters (such as insulin sensitivity index, total cholesterol, and NEFA levels) did not vary significantly between groups (Fig. 2, E-H , and data not shown). Liver TG concentration (an important component of metabolic syndrome) (20) was normal in the HPD group but remained high in the CD group (Fig. 2I) . Hepatic TG concentration was proportional to the weight of abdominal fat and to plasma TG concentration.
Glucose and hormones respond differently to refeeding of each diet. To clarify the effects of HPD or CD feeding on the metabolism of plasma glucose and hormones, we measured pre-and postprandial plasma parameters during refeeding tests (Table 3 ). There were no significant differences in plasma glucose, insulin, or glucagon concentrations before feeding among the three groups. Each group of rats was fed equal quantities of energy from each diet during the 5-min refeeding. After refeeding, all groups exhibited significant increases in PGC-1␣  109  NM_031347  F: 5Ј-TGTTCGATGTGTCGCCTTCT-3Ј  R: 5Ј-GAACGAGAGCGCATCCTTTG-3Ј  PPAR␣  112  NM_013196  F: 5Ј-TGTATGAAGCCATCTTCACG-3Ј  R: 5Ј-GGCATTGAACTTCATAGCGA-3Ј  CPT I␣  104 plasma glucose and insulin concentrations at 30 min, but only the HPD group showed a significant increase in plasma glucagon concentration (P Ͻ 0.05 vs. premeal). Postprandial insulin concentrations were similar in all groups, but postprandial glucose concentration was significantly lower in the HPD group than in the other groups. In summary, rats fed the HPD exhibited lower glycemic and higher glucagonemic potency than those fed the CD.
HPD ameliorates fasting and postprandial hypertriglyceridemia. Oral fat tolerance was tested to assess postprandial TG response and whole body lipid clearance. In the HPD group, pre-and postprandial plasma TG concentrations returned to normal levels by the 8th day of phase 2 ( Fig. 3A) . Although the incremental areas under the plasma TG curves from 0 to 4 h were similar among all groups (Fig. 3B) , pre-and postprandial plasma TG concentrations remained significantly higher in the CD group.
HPD induces expresssion of lipolysis and fatty acid utilization-related genes in liver.
To elucidate the cellular mechanisms underlying these differences, we examined the expression of genes that regulate lipid homeostasis in the liver (Fig. 4,  A and B) . Genes involved in fatty acid oxidation are regulated in part by peroxisome proliferator-activated receptor (PPAR)␥ coactivator-1␣ (PGC-1␣) in a PPAR␣-dependent manner (19) . Relative to lean rats, obese rats fed the HPD, but not those fed the CD, showed increased levels of PGC-1␣ and PPAR␣ gene expression (P Ͻ 0.05, HPD vs. lean group). There also was a trend toward increased expression of carnitine palmitoyl transferase I␣ (CPT I␣) and acyl-CoA oxidase (ACOX), target genes of PPAR␣, in the HPD group relative to the CD group (CPT I␣: P ϭ 0.08; ACOX: P Ͻ 0.05).
Hepatic lipogenesis-related genes are regulated by insulin via sterol regulatory element-binding protein-1c (SREBP1c)-dependent manner (34) . We couldn't see any differences in plasma insulin level or expression level of SREBP-1c in the liver among the three groups (Figs. 2G and 4A ). In contrast, expression levels of key genes for de novo lipogenesis, such as acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), and stearoyl-CoA desaturase-1 (SCD-1), were suppressed in the HPD group but not in the CD group (ACC and SCD-1: P Ͻ 0.05; FAS: P ϭ 0.09). We observed positive correlations between the level of SCD-1 gene expression and the amount of carbohydrate intake in all rats (n ϭ 18, r ϭ 0.72, P Ͻ 0.05). There also was a positive correlation between levels of SCD-1 gene expression and fasting plasma TG in obese rats (n ϭ 13, r ϭ 0.64, P Ͻ 0.05; Fig. 5 ) but not in lean rats (n ϭ 5, r ϭ 0.77, P Ͼ 0.1; Fig.  5 ). Lipolytic genes regulated by fibroblast growth factor-21 (FGF21), such as pancreatic lipase (PNLIP) and hormonesensitive lipase (HSL), were upregulated during HPD feeding (P Ͻ 0.05 vs. lean group). Expression of adipose triacylglycerol lipase, another lipolytic gene, was also significantly higher in the HPD group than in the CD group. Furthermore, lipid metabolism-related genes, such as liver fatty acid-binding protein 1 (FABP1), dienoyl-CoA reductase 1 (DECR1), and 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2), were also expressed at levels that were significantly higher in the HPD group than in the CD group.
To investigate which of these genes is most critical for lipid utilization in the liver, we looked for significant correlations between liver TG concentration and lipid homeostasis-related gene expression. Among the genes exam- ined, FGF21 was the only gene whose expression correlated significantly with liver TG concentrations in the obese group (r ϭ Ϫ0.55, P Ͻ 0.05) but not in the lean group (Fig. 6, A  and B) .
Glucagon stimulates FGF21 expression in primary hepatocytes.
To further investigate the induction of FGF21 gene expression and its linkage with hepatic TG concentration, we focused on hepatic glucagon signaling. In a study by Charbonneau et al. (7) in which exercise training increased plasma glucagon levels and improved fatty liver, a negative correlation between liver fat and the density of glucagon receptors in the membrane was found. In the present study, both glucagon receptor gene expression and postprandial plasma glucagon levels were higher in the HPD group than in the CD group (Table 3 and Fig. 4B ). In rat primary hepatocytes, we found that FGF21 gene expression was both upregulated by glucagon and suppressed by insulin in a dose-dependent manner (Fig. 7) .
DISCUSSION
In the present study, we examined cellular mechanisms that drive the significantly greater amelioration of sucrose-induced obesity, hypertriglyceridemia, and fatty liver in rats with caloric restriction and a HPD relative to a CD. Results from gene expression analyses implicated two potential targets underlying the effectiveness of the hypocaloric HPD. First, the expression Data represent means Ϯ SE (n ϭ 5-7 rats/group). CD, control diet; HPD, high-protein diet. Energy intake and changes in plasma parameter concentrations during the refeeding test. *P Ͻ 0.05 vs. lean group; †P Ͻ 0.05 vs. CD group; ‡P Ͻ 0.05 vs. premeal. of SCD-1, which is regulated primarily by the amount of dietary carbohydrate and reflects fasting plasma TG levels, was markedly reduced in the HPD group. Second, FGF21 gene expression levels, which correlate negatively with TG concentration in obese rat livers, mediate the expression of liver lipolytic and lipid utilization genes that were upregulated in HPD-fed rats.
After refeeding, the HPD has higher glucagonemic potency than the CD. Glucagon secretion is predominantly inhibited by insulin, but the HPD stimulated glucagon secretion without decrease in insulin in the present study. Several investigators have also observed that the HPD has the same effects in rodents and humans (4, 14) . In addition, the HPD has lower glycemic action but higher glucagon level. Baum et al. (4) reported that HPD feeding has lower glycemic action and enhanced hepatic gluconeogenesis at the same time. In this study, we observed the same dietary effects on the metabolic and hormonal status as those described above; therefore, it is concluded that our experimental setting and results reflect real situations.
Lipid clearance rates in peripheral tissues, as well as the balance between lipid synthesis and utilization in the liver, maintain whole body lipid homeostasis. We initially examined the effects of energy-restricted diets with different compositions of macronutrients on peripheral TG clearance rate using an oral fat tolerance test. Although fasting and postprandial TG concentrations in the HPD group were significantly lower than those in the CD group, there was no significant difference in Fig. 3 . HPD ameliorates fasting and postprandial hypertriglyceridemia. Changes in plasma TG concentrations (A) and incremental areas under the plasma TG curves (AUC; B) during oral fat tolerance test (2 g/kg body wt). Data represent means Ϯ SE (n ϭ 5-7 rats/group). Using repeated-measures ANOVA, dietary intervention had a significant effect on the index of plasma TG concentrations observed in the different lettered groups; P Ͻ 0.05. incremental area under the curve from 0 to 4 h between groups. These results indicate that whole body TG homeostasis, including rates of absorption from the intestine and clearance via peripheral lipase, does not differ between groups and suggests that differences between fasting and postprandial TG concentrations arise primarily from VLDL-TG secretion from the liver.
The effects of energy-restricted diets that include different compositions of macronutrients on TG metabolism in the liver were tested. The three potential pathways for TG metabolism include 1) TG production by de novo lipogenesis, 2) degradation of liver TG by lipolysis, and 3) utilization for energy and ketone body production through ␤-oxidation.
Dietary carbohydrate is a main source of de novo lipogenesis. Hepatic SCD-1 gene expression, regulated primarily by carbohydrate intake in the present study, has been observed in adipose tissue under isocaloric and hypocaloric conditions (22) . Hepatic SCD-1 gene expression is also regulated by the insulin/SREBP-1c pathway, but there were no significant differences in the plasma insulin level and the expression levels of SREBP-1c among all three groups. In addition, carbohydrate intake could induce SCD-1 gene in SREBP-1c-null mice (23) . These results suggest that expression levels of SCD-1 gene are in part regulated in a carbohydrate intake-dependent manner. SCD activity, in the liver in particular, has been noted to reflect plasma TG levels (2, 22) . We observed a positive correlation between hepatic SCD-1 gene expression and fasting plasma TG levels in the obese group during weight loss. These results indicate that dietary carbohydrate intake may determine the rate of VLDL-TG synthesis via hepatic SCD-1 in obese rats under calorie restriction.
The role of SCD-1 in lipid metabolism has been studied extensively (8, 26) . Whole body SCD-1-knockout mice are lean and show reduced adiposity and decreased hepatic fat content, suggesting that SCD-1 deficiency protects mice from fatty liver (8, 26) . However, despite the dramatic downregulation of SCD-1 gene expression sustained in 14-wk-old mice, hepatic steatosis can develop with a high-fat diet (35) . For this reason, a simple decrease in SCD-1 gene expression alone does not appear to be able to explain the improvement of fatty liver noted in the HPD group.
Rats fed a HPD also showed increased expression of liver lipolytic genes such as PNLIP and HSL, which hydrolyze TG (1). Inagaki et al. (18) have reported that FGF21 regulates these lipolytic genes and that FGF21 stimulates fatty acid utilization for energy and ketone body production. FGF21 knockdown mice also show accelerated hepatic TG accumulation when fed a high-fat diet (3). In addition, FGF21 administration improved high-fat diet-induced fatty liver (37) . In the present study, TG concentrations showed a negative correlation with FGF21 gene expression levels in the liver. These data indicate that FGF21 regulates hepatic TG levels partly through intrahepatic lipolysis.
FGF21 gene expression was also induced by glucagon treatment of rat primary hepatocytes, suggesting that a HPD may elicit a glucagon secretagogue effect, allowing glucagon/ FGF21 signaling to ameliorate a fatty liver. Exercise training has also been shown to enhance glucagon signaling and ameliorate TG accumulation in the liver (6, 7). Charbonneau et al. (7) reported that glucagon signaling accounts for 26% of hepatic TG concentrations in rats with or without exercise (r ϭ Ϫ0.51). In the present study, glucagon/FGF21 signaling could account for 31% of liver TG concentration (r ϭ Ϫ0.55). These data suggest that HPD ameliorates fatty liver due to glucagon secretagogue action.
Fatty acid utilization is controlled primarily by insulin and glucagon, both of which respond to the balance of dietary macronutrients. Glucagon directs fatty acids to a metabolic fate by stimulation of lipolysis. Fatty acids are then shunted toward energy and alternative fuel production via ␤-oxidation and ketogenesis. In the present study, normal levels of ACOX gene expression were reduced in animals fed the CD and restored in HPD-fed rats. ACOX encodes an enzyme that regulates peroxisomal fatty acid oxidation and uses saturated fatty acids Fig. 6 . Hepatic FGF21 gene is an important regulator of TG concentration during weight loss. Relationship between hepatic FGF21 gene expression and HTGC in lean (A) and obese (B) rat groups. Using Spearman's rank correlation, hepatic FGF21 gene expression correlated significantly with liver TG concentration in obese rats; r ϭ 0.55, P ϭ 0.02. Fig. 7 . Glucagon/insulin ratio regulates FGF21 gene expression in rat primary hepatocytes. Glucagon and/or insulin stimulation was performed in rat primary hepatocytes, and relative levels of FGF21 transcript were measured. Data represent means Ϯ SE (n ϭ 3). *Concentration-dependent effects were observed using regression analysis; P Ͻ 0.05. primarily for fuel. ACOX Ϫ/Ϫ mice show no peroxisomal ␤-oxidation and have severe fatty livers (11) . Because a highcarbohydrate diet induces adiposity by overproducing saturated fatty acids, induction of ACOX may be useful in the treatment of fatty liver.
Other key genes encoding proteins involved in fatty acid metabolism and ketone body biosynthesis, such as FABP1, DECR1, and HMGCS2, were also upregulated in HPD-fed mice and have been shown to be stimulated by glucagon via PGC-1␣ and PPAR␣ activation pathways (16, 27, 28) . Short-term repression of FGF21 also suppressed ACOX and HMGCS2 gene expression in the liver (3) . These data suggest that, in HPD-fed rats, glucagon/FGF21 signaling has an effect on fatty acid transport, oxidation, and metabolism-related genes in the liver.
In conclusion, hypocaloric HPD feeding reduces abdominal, plasma, and liver TG levels in sucrose-fed obese rats. Two mechanistic pathways contribute to the beneficial effects of HPD feeding in obese rats, stimulation of hepatic lipolysis and lipid utilization mediated by glucagon/FGF21 signaling and reduction of VLDL-TG production regulated by a carbohydrate-SCD-1 axis.
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